Trivitron Healthcare’s Labsystems Diagnostics OY, has inked three memorandum of understanding with the  University of Turku and Indian Translational Health Science Technology Institute (THSTI). The Indo-Finland initiative will be first of its kind in developing an affordable medical point of care diagnostics device for use in India and other developing countries.

The diagnostic platform can be used for testing cardiac troponin-I for acute coronary syndrome besides high sensitive detection infectious diseases, cancer markers, new born screening panel etc. The research was funded by Indian Department of Biotechnology under the Ministry of Science and Technology, Tekes, the Finnish Funding Agency for Innovation and the Academy of Finland.

Finland-based Labsystem diagnostics which has a manufacturing and marketing network in India, Africa and Asia, will now manufacture the same at new facility in Trivitron Medical Technology park in Chennai .

The three MOUs were signed as part of the Indo-Finland inititiave in the presence of President of India Pranab Mukherjee at Helsinki.

According to Dr. GSK Velu, founder and managing director, Trivitron Healthcare, “the MoU would promote academic and commercial cooperation in research and development between Indian and Finnish medical technology players for in- vitro diagnostics. It will enable affordable and accessible to healthcare.

The pact with the University of Turku and Nordic Institute for Dental Education to focus on skill development initiatives in Healthcare sector with focus on advanced medical technologies”.

The key objective is to develop high performing yet easy-to-use diagnostic tests for near-patient use in both developed and developing countries. The diagnostic platform will act as a boon for patients with critical medical conditions such as myocardial infarction, infectious diseases diagnosis, early cancer detection etc.

Through close collaboration in translational research and development, the partners seek to develop unique expertise for the design of novel, simple and affordable diagnostic tests and test platforms to the global market. This will be achieved by encouraging exchange of researchers as well as recruitment of students to the international master’s degree and doctoral programmes of the University of Turku.

A third memorandum was also signed between Trivitron Healthcare, Planmeca OY & Nordic Institute of Dental Education . The effort is to enhance business and educational cooperation between Planmeca, NIDE and Trivitron, expand offering of dental technology through skill development courses in India to the dental community, he said.